Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus

被引:184
作者
Parrilla, P [1 ]
de Haro, LFM [1 ]
Ortiz, A [1 ]
Munitiz, V [1 ]
Molina, J [1 ]
Bermejo, J [1 ]
Canteras, M [1 ]
机构
[1] Univ Hosp Virgen Arrixaca, Dept Surg, Murcia 30120, Spain
关键词
D O I
10.1097/00000658-200303000-00001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To compare the results of medical treatment and antireflux surgery in patients with Barrett's esophagus (BE). Summary Background Data The treatment of choice in BE is still controversial. Some clinical studies suggest that surgery could be more effective than medical treatment in preventing BE from progressing to dysplasia and adenocarcinoma. However, data from prospective comparative studies are necessary to answer this question. Methods One hundred one patients were included in a randomized prospective study, 43 with medical treatment and 58 with antireflux surgery, All patients underwent clinical, endoscopic, and histologic assessment. Functional studies were performed in all the operated patients and in a subgroup of patients receiving medical treatment. The median follow-up was 5 years (range 1-18) in the medical treatment group and 6 years (range 1-18) in the surgical treatment group. Results Satisfactory clinical results (excellent to good) were achieved in 39 of the 43 patients (91%) undergoing medical treatment and in 53 of the 58 patients (91%) following antireflux surgery. The persistence of added inflammatory lesions was significantly higher in the medical treatment group. The metaplastic segment did not disappear in any case. Postoperative functional studies showed a significant decrease in the median percentage of total time with pH below 4, although 9 of the 58 patients (15%) showed pathologic rates of acid reflux. High-grade dysplasia appeared in 2 of the 43 patients (5%) in the medical treatment group and in 2 of the 58 patients (3%) in the surgical treatment group. In the latter, both patients presented with clinical and pH-metric recurrence. There was no case of malignancy after successful antireflux surgery. Conclusions These results show that there are no differences between the two types of treatment with respect to preventing BE from progressing to dysplasia and adenocarcinoma. However, successful antireflux surgery proved to be more efficient than medical treatment in this sense, perhaps because it completely controls acid and biliopancreatic reflux to the esophagus.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 28 条
[1]   LONG-TERM AMBULATORY ENTEROGASTRIC REFLUX MONITORING - VALIDATION OF A NEW FIBEROPTIC TECHNIQUE [J].
BECHI, P ;
PUCCIANI, F ;
BALDINI, F ;
COSI, F ;
FALCIAI, R ;
MAZZANTI, R ;
CASTAGNOLI, A ;
PASSERI, A ;
BOSCHERINI, S .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (07) :1297-1306
[2]   Barrett's esophagus: continuing questions and controversy [J].
Castell, DO ;
Katzka, DA .
GASTROINTESTINAL ENDOSCOPY, 1999, 49 (03) :S5-S8
[3]   Results of the Collis-Nissen gastroplasty in patients with Barrett's esophagus [J].
Chen, LQ ;
Nastos, D ;
Hu, CY ;
Chughtai, TS ;
Taillefer, R ;
Ferraro, P ;
Duranceau, AC .
ANNALS OF THORACIC SURGERY, 1999, 68 (03) :1014-1020
[4]   Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus:: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation [J].
Csendes, A ;
Braghetto, I ;
Burdiles, P ;
Puente, G ;
Korn, O ;
Díaz, JC ;
Maluenda, F .
SURGERY, 1998, 123 (06) :645-657
[5]   Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux [J].
de Haro, LM ;
Ortiz, A ;
Parrilla, P ;
Munitiz, V ;
Molina, J ;
Bermejo, J ;
Rios, A .
ANNALS OF SURGERY, 2001, 233 (01) :34-38
[6]  
HINDER RA, 1995, SURG ENDOSC-ULTRAS, V9, P1328
[7]   Long-term outcome of antireflux surgery in patients with Barrett's esophagus [J].
Hofstetter, WL ;
Peters, JH ;
DeMeester, TR ;
Hagen, JA ;
DeMeester, SR ;
Crookes, PF ;
Tsai, P ;
Banki, F ;
Bremmer, CG .
ANNALS OF SURGERY, 2001, 234 (04) :532-538
[8]  
Katz D, 1998, AM J GASTROENTEROL, V93, P536
[9]  
KATZKA DA, 1994, AM J GASTROENTEROL, V89, P989
[10]   Long-term omeprazole treatment in resistant gastroesophageal reflux disease:: Efficacy, safety, and influence on gastric mucosa [J].
Klinkenberg-Knol, EC ;
Nelis, F ;
Dent, J ;
Snel, P ;
Mitchell, B ;
Prichard, P ;
Lloyd, D ;
Havu, N ;
Frame, MH ;
Romàn, J ;
Walan, A .
GASTROENTEROLOGY, 2000, 118 (04) :661-669